RushNet (RushNet) Debt-to-EBITDA : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is RushNet Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

RushNet's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. RushNet's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. RushNet's annualized EBITDA for the quarter that ended in . 20 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for RushNet's Debt-to-EBITDA or its related term are showing as below:

RSHN's Debt-to-EBITDA is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.83
* Ranked among companies with meaningful Debt-to-EBITDA only.

RushNet Debt-to-EBITDA Historical Data

The historical data trend for RushNet's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Debt-to-EBITDA Chart

RushNet Annual Data

Trend

Debt-to-EBITDA

RushNet Quarterly Data

Debt-to-EBITDA

Competitive Comparison of RushNet's Debt-to-EBITDA

For the Diagnostics & Research subindustry, RushNet's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RushNet's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RushNet's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where RushNet's Debt-to-EBITDA falls into.

RushNet Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

RushNet's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	N/A
	=	N/A

RushNet's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.

RushNet (OTCPK:RSHN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

RushNet Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of RushNet's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

RushNet (RushNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222

Website

https://www.rushnetinc.com

RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.